Source: https://tradeasduck.com/ideas/pfe/
Retrieved: 2026-11-19

[Archive](https://tradeasduck.com/ideas/) › PFE

# PFE trade ideas: every closed DuckWise idea on Pfizer, Inc.

DuckWise has published 1 idea on Pfizer, Inc. (PFE, Stock) that has closed between June 2020 and July 2020. Each is listed below with the levels published before the position was taken and its result at close — 1 in profit, 0 at a loss.

**1** closed idea

**1 / 0** in profit / at a loss

**+17.11%** average result

**50 days** typical holding period

| Opened | Closed | Side | Entry | Stop | Projection | Close | Result | Days |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2020 | Jul 22, 2020 | Long | 34.07 | — | 40 | 39.90 | +17.11% | 50 |

Prices in US dollars. Prices are as traded on the day. Result is the price change from the published entry to the published close plus dividends received while the idea was held (paid, for shorts), before fees, taxes and slippage. [How results are counted](https://tradeasduck.com/methodology/).

## PFE questions and answers

### Has DuckWise published trade ideas on PFE?

Yes. DuckWise has published 1 idea on Pfizer, Inc. (PFE) that closed between June 2020 and July 2020: 1 closed in profit and 0 at a loss. The average result was +17.11% from the published entry to the published close, dividends included.

### What was the latest closed DuckWise idea on PFE?

A long idea opened on June 2, 2020 with an entry of $34.07 and a price projection of $40.00. It closed on July 22, 2020 at $39.90, a result of +17.11% after 50 days.

### How long did DuckWise hold its PFE ideas?

The typical PFE idea was held about 50 days from entry to close. DuckWise ideas are swing and position trades, not day trades.

### Is there an open DuckWise idea on PFE right now?

Not at the moment. When DuckWise publishes a new idea on PFE, app subscribers get a push notification; it appears on this page once it closes.

### Is this page a stock forecast for PFE or a recommendation to buy it?

No. This page records closed ideas only. Each price projection was a published level for a model idea, not a forecast of where PFE will trade. The research is general and impersonal, not a recommendation to buy or sell PFE or any other security.

## More trade ideas on the record
- [ORCL](https://tradeasduck.com/ideas/orcl/) Oracle Corporation · 12 ideas
- [OXY](https://tradeasduck.com/ideas/oxy/) Occidental Petroleum Corporation · 1 idea
- [PANW](https://tradeasduck.com/ideas/panw/) Palo Alto Networks, Inc. · 1 idea
- [PLTR](https://tradeasduck.com/ideas/pltr/) Palantir Technologies Inc. · 9 ideas
- [PLUG](https://tradeasduck.com/ideas/plug/) Plug Power Inc. · 1 idea
- [PVH](https://tradeasduck.com/ideas/pvh/) PVH Corp. · 2 ideas
- [AMZN](https://tradeasduck.com/ideas/amzn/) Amazon.com, Inc. · 25 ideas
- [TSLA](https://tradeasduck.com/ideas/tsla/) Tesla, Inc. · 22 ideas
- [CRM](https://tradeasduck.com/ideas/crm/) Salesforce, Inc. · 18 ideas
- [LRCX](https://tradeasduck.com/ideas/lrcx/) Lam Research Corporation · 16 ideas
- [GOOG](https://tradeasduck.com/ideas/goog/) Alphabet Inc. · 15 ideas
- [ON](https://tradeasduck.com/ideas/on/) ON Semiconductor Corporation · 15 ideas
- [AAPL](https://tradeasduck.com/ideas/aapl/) Apple Inc. · 14 ideas
- [AMD](https://tradeasduck.com/ideas/amd/) Advanced Micro Devices, Inc. · 14 ideas

[Every ticker in the archive](https://tradeasduck.com/ideas/) · [Track record by year](https://tradeasduck.com/)

## About Pfizer, Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. Pays a dividend yield of 5.95% annually.

These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell PFE or any other security.

---
Model-portfolio results calculated from published entry and close levels plus dividends — not the returns of any real account; fees, taxes and slippage are not included; past results are not a reliable indicator of future results. General, impersonal research — not investment advice and not a recommendation to buy or sell any security.
